NCT04938336Completed
Evaluation of a Decision Aid Tool in Rectal Cancer patiënts
Source: ClinicalTrials.gov · Last updated 11 Jul 2024
Brief summary (registry, in English)
Adapt and evaluate a decision aid for patients with rectal cancer. Phase 1 : decision aid testing (Delphi) multicentric Phase 2: pilot test decision aid
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 70 (actual)
- First submitted
- 1 Jun 2021
- Start date
- 22 Apr 2022
- Primary completion date
- 10 Jul 2024
- Lead sponsor
- University Hospital, Ghent
- Diseases
- Colorectal cancer
- NCT number
- NCT04938336
What you commit to
- Study type: Observational
- Participants enrolled: 70
- From 22 Apr 2022 to the primary completion date, 10 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- none
- Interviews Inclusion criteria
- Patients in which the decision aid was tested
- patients with a tumor in the last 10cm of the rectum
- healthcare professionals who have used the decision aid tool
- informal carer indicated by the patient Exclusion
- patients who have no treatment choice due to oncological reasons
Who the study is looking for
- expert healthcare professionals caring for patients with rectal cancer
Criteria the registry did not label
- Delphi procedure
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Ghent Coordinator of this site? Confirm its status | Ghent | Belgium | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.